CNTA - Balance Sheet - Centessa Pharmaceuticals plc

Current Liabilities	58 M
Accounts Payable	7.14 M
Short-Term Debt	0
Other Current Liabilities	50.9 M
Non-Current Liabilities	117 M
Long-Term Debt	109 M
Other Non-Current Liabilities	8.32 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	383.2	128.0	393.6	595.1	7.2
Short Term Investments	99.0	128.5	0	0	0
Receivables	0	39.1	26.7	16.8	0
Inventory	0	1	(30.0)	(17.8)	1.0
Other Current Assets	1.8	19.4	17.4	16.9	3.9
Total Current Assets	536.4	315.1	393.6	595.1	11.2
PP&E	11.8	13.0	1.2	0.2	0
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	0	0	0	0	0
Other Long Term Assets	2.0	2.6	46.0	34.4	0.6
Other Assets	0	0	0	0	0
Total Assets	576.8	360.2	444.3	629.6	11.7
LIABILITIES
Accounts Payable	7.1	11.8	13.8	7.3	1.0
Short Term Debt	0	0	0	0	5.6
Other Current Liabilities	50.0	27.5	22.9	16.6	2.0
Total Current Liabilities	58.0	39.4	38.3	24.6	8.6
Long Term Debt	108.9	84.6	69.8	75.7	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	8.3	29 K	0	37.7	0
Total Liabilities	175.3	124.0	108.1	138.1	34.1
EQUITY
Common Stock	0.4	0.3	0.3	0.3	21 K
Retained Earnings	(988.7)	(752.9)	(601.9)	(385.7)	(22.4)
Other Accumulative Comprehensive Income/Loss	4.2	1.5	(1.5)	0.7	86 K
Total Equity	401.5	236.2	336.2	491.6	(22.4)
Total Liabilities and Equity	576.8	360.2	444.3	629.6	11.7
SHARES OUTSTANDING
Common Shares Outstanding	114.5	96.2	93.4	90.0	142.1	70.9

Free